Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats
Authors:
- 8 December 2012
- journal article
- Published by Taylor & Francis in Drug Delivery
- Vol. 20 (1) , 25-33
Abstract
In this paper, orally nanocrystal capsules were produced using nanocrystal formulations in order to optimize dissolution properties of poorly soluble drug glimepiride and improve its bioavailability. The important preparation variables, such as stabilizers, the power input and the time length of ultrasonication on the mean particle size and polydispersity index were investigated systematically, and the optimal values were 0.2% glimepiride (w/v), 1.2% Lipoid S100, 0.6% PEG 6000 (w/v), 0.6% PVPK 30 (w/v), 500 W and 2 min, respectively. Characterization of glimepiride nanocrystal was carried out by X-ray powder diffractometry, differential scanning calorimetry and scanning electron microscopy. In vitro dissolution test, the nanocrystal-loaded capsules of glimepiride showed an evident increase in dissolution rate compared to micronized and market capsules. The in vivo studies demonstrated that a marked enhancement of bioavailability of nanocrystal-loaded capsules was superior compared to the marketed formulation and microcrystal-loaded capsules, which may reduce the risk of side effect by allowing a reduction in either the dose or its frequency of administration.Keywords
This publication has 22 references indexed in Scilit:
- Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicamInternational Journal of Pharmaceutics, 2009
- Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approachesInternational Journal of Pharmaceutics, 2009
- Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous deliveryInternational Journal of Pharmaceutics, 2009
- Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid productsInternational Journal of Pharmaceutics, 2008
- Nanosizing — Oral formulation development and biopharmaceutical evaluationAdvanced Drug Delivery Reviews, 2007
- Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Efficacy of glimepiride in Japanese type 2 diabetic subjectsDiabetes Research and Clinical Practice, 2005
- The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugsInternational Journal of Pharmaceutics, 2004
- Amorphous Drug Delivery Systems: Molecular Aspects, Design, and PerformanceCritical Reviews™ in Therapeutic Drug Carrier Systems, 2004
- Production and Characterization of a Budesonide Nanosuspension for Pulmonary AdministrationPharmaceutical Research, 2002